Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Lonza Group Appoints Samanta Cimitan As Chief Commercial Officer

RECENTLY ACQUIREDAug 26, 2026•about 5 hours ago

Position

Chief Commercial Officer

Company

Lonza's Personalized Medicine Business

Samanta Cimitan
BaselManufacturingBiotechnologyPharmaceuticalpharmaceuticals

Description

Lonza Group has appointed Samanta Cimitan as chief commercial officer, senior vice president, and a member of its extended executive committee. Dr. Cimitan will join the company by January 1, 2027.

Company Information

Company

Lonza's Personalized Medicine Business

Location

38 Muenchensteinerstrasse

Basel, Basel City, Switzerland

About

Lonza's Personalized Medicine Business is a specialized division focusing on cell therapy and biomedicine. They offer services and technologies to support the development of personalized medicine solutions. The business has played a significant role in advancing cell therapy applications. It has been involved in global initiatives related to personalized medical products.

Don't miss Lonza's Personalized Medicine Business's next move

Get an email the moment Lonza's Personalized Medicine Business changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Wolfgang
Likely contact at this company
••••••••@••••••••

See Wolfgang's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Lonza's Personalized Medicine Business's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Lonza's Personalized Medicine Business changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.